Tevogen Bio Holdings Announces Key Financial and Governance Moves
Company Announcements

Tevogen Bio Holdings Announces Key Financial and Governance Moves

Tevogen Bio Holdings (TVGN) has issued an announcement.

Tevogen Bio Holdings Inc. has engaged in a securities purchase agreement, selling 600 shares of its Series C Preferred Stock to an investor for $6 million. These shares, which will begin to be convertible into common stock six months post-issuance, come with a 7.5% annual cumulative dividend and a Beneficial Ownership Limitation to prevent any single investor from holding over 9.99% of the common stock. Furthermore, the company reserves a call right on these shares after five years and has established that Series C stockholders must approve any adverse changes to the company’s governing documents. Concurrently, Suren Ajjarapu resigned from the board of directors, with no disputes cited regarding company operations or policies.

Find detailed analytics on TVGN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTevogen leverages Microsoft partnership to deliver target identification for HPV
TheFlyTevogen regains compliance with Nasdaq
TheFlyBoeing to offer 90M common shares, Philips reports mixed Q3: Morning Buzz
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App